Benitec Biopharma’s (BNTC) “Buy” Rating Reiterated at HC Wainwright
HC Wainwright reissued their buy rating on shares of Benitec Biopharma (NASDAQ:BNTC – Free Report) in a research report sent ...
Ardelyx’s (ARDX) Neutral Rating Reiterated at HC Wainwright
HC Wainwright reiterated their neutral rating on shares of Ardelyx (NASDAQ:ARDX – Free Report) in a research report sent to ...
H.C. Wainwright says SEC plan to dismiss suit lifts ‘major overhang’ on Coinbase
H.C. Wainwright analyst Mike Colonnese notes that Coinbase (COIN) announced that the Securities and Exchange Commission has agreed to dismiss ...
H.C. Wainwright Sticks to Its Hold Rating for Biotricity (BTCY)
H.C. Wainwright analyst Kevin Dede maintained a Hold rating on Biotricity (BTCY – Research Report) today. The company’s shares closed yesterday ...
Hosted on MSN16d
HC Wainwright & Co. Initiates Coverage of Vertical Aerospace (EVTL) with Buy Recommendation
Fintel reports that on February 7, 2025, HC Wainwright & Co. initiated coverage of Vertical Aerospace (NYSE:EVTL) with a Buy recommendation. Analyst Price Forecast Suggests 94.58% Upside As of ...
Investing19d
H.C. Wainwright maintains buy on Northern Dynasty stock
Tuesday, H.C. Wainwright reaffirmed its Buy rating on Northern Dynasty Minerals (NYSE:NAK) with a steady price target of $1.30, representing significant upside from the current trading price of $0.65.
Investing20d
H.C. Wainwright maintains buy on Northern Dynasty stock
Tuesday, H.C. Wainwright reaffirmed its Buy rating on Northern Dynasty Minerals (NYSE:NAK) with a steady price target of $1.30, representing significant upside from the current trading price of $0.65.
Nasdaq20d
HC Wainwright & Co. Initiates Coverage of CRISPR Therapeutics (BRSE:1CG) with Buy Recommendation
Fintel reports that on February 3, 2025, HC Wainwright & Co. initiated coverage of CRISPR Therapeutics (BRSE:1CG) with a Buy recommendation. There are 575 funds or institutions reporting positions ...